Table 6.
p-value* | Placebo | Ginger | Response |
---|---|---|---|
Acute phase | |||
0.93 | 2.27 ± 4.88 | 2.18 ± 5.03 | Duration** of nausea in day 1 |
Delayed phase | |||
0.59 | 5.10 ± 9.66 | 3.06 ± 7.61 | Duration of nausea in day 2 |
0.82 | 3.80 ± 8.55 | 2.67 ± 6.76 | Duration of nausea in day 3 |
*p- values were calculated using Wilcoxon Signed Rank test. **Duration ofnausea reported as total h of feeling nausea during a day (19).